You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 4, April 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Enucleation
 •Radiation Therapy
 •Statistics and Research Methods
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Preenucleation Radiotherapy, Uveal Melanoma, and Competing Risks—Reply

Emine Kilic, MD, PhD; Theo Stijnen, PhD; Gre P. M. Luyten, MD, PhD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

In the October 2005 issue of the Archives, we reported that preenucleation external beam radiotherapy has a beneficial effect on survival of patients with uveal melanoma.1 Survival after 4 years of follow-up was better in the PER group. Death due to all causes and melanoma-related death were compared between PER and EO, corrected for age and other potential confounders. Unadjusted survival curves were given as a graphical illustration. In both analyses, the risk of death was significantly lower from 4 years onward in the PER group.

Kivelä and Kujala observe that our results differ from those of the Collaborative Ocular Melanoma Study2 and suggest that this might be owing to our statistical analysis being possibly biased. Unfortunately, we disagree. Kivelä and Kujala are not critical with respect to our results for death due to . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Reduced Melanoma-Related Mortality in Uveal Melanoma by Preenucleation Radiotherapy
Emine Kilic, Theo Stijnen, Paulus T. V. M. de Jong, Cornelia M. Mooy, Wilhelmina M. H. Eijkenboom, Peter J. Ringens, and Gre P. M. Luyten
Arch Ophthalmol. 2005;123(10):1363-1367.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Pulmonary Metastasis Masquerading as Anterior Uveitis
Muge R. Kesen, Deepak P. Edward, Lawrence J. Ulanski, Howard H. Tessler, and Debra A. Goldstein
Arch Ophthalmol. 2008;126(4):572-574.
EXTRACT | FULL TEXT  

Preenucleation Radiotherapy, Uveal Melanoma, and Competing Risks
Tero Kivelä and Emma Kujala
Arch Ophthalmol. 2008;126(4):580-581.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.